What medications should be avoided in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications to Avoid in Children

Several medication classes should be avoided in children due to safety concerns, including over-the-counter cough and cold medications in children under 6 years, certain antidepressants, and medications with narrow therapeutic indices that can be fatal with minimal exposure. 1, 2

Over-the-Counter Medications

  • OTC cough and cold medications should be avoided in all children below 6 years of age due to lack of proven efficacy and potential toxicity 1
  • Between 1969 and 2006, there were 54 fatalities associated with decongestants (pseudoephedrine, phenylephrine, and ephedrine) in children under 6 years, with 43 deaths occurring in children under 1 year 1
  • During the same period, 69 fatalities were associated with antihistamines (diphenhydramine, brompheniramine, and chlorpheniramine) in children under 6 years 1
  • Topical decongestants should be used with caution in children under 1 year due to the narrow margin between therapeutic and toxic doses, increasing the risk for cardiovascular and CNS side effects 1

Antibiotics and Antimicrobials

  • Linezolid should be avoided in children with significant anemia, leukopenia, thrombocytopenia, or peripheral neuropathy 1
  • Clofazimine should be avoided in children with a baseline QTc interval greater than 500 ms that does not correct with medical management 1
  • Unnecessary antibiotics, such as those prescribed for viral infections, should be withheld to prevent adverse effects 3

Antidepressants and Psychiatric Medications

  • Selective serotonin reuptake inhibitors (SSRIs) like paroxetine should not be used in patients with major depression who are under 18 years of age due to an elevated risk of suicidal thoughts and acts 1
  • Venlafaxine has shown increased rates of harmful outcomes including hostility, suicidal ideation, and self-harm in children compared to placebo 1
  • Tricyclic antidepressants have been shown to lack efficacy in children and can be fatal with minimal exposure 1, 2

Potentially Fatal Medications with Minimal Exposure

  • Tricyclic antidepressants, antipsychotics, quinine derivatives, calcium channel blockers, opioids, and oral hypoglycemics can kill a toddler with just 1-2 dose units 2
  • These high-risk medications were responsible for 40% of toddler fatalities reported to poison control centers between 1990-2000 2
  • Amoxicillin overdosages of less than 250 mg/kg are generally not associated with significant clinical symptoms, but higher doses can cause interstitial nephritis and crystalluria 4

Medications Requiring Special Monitoring

  • Medications with QTc prolongation risk require baseline and monthly ECG monitoring in children, including clofazimine and certain antituberculosis drugs 1
  • Linezolid requires monthly screening for peripheral neuropathy and complete blood counts 1
  • Flunarizina should be started at lower doses (5 mg/day) in older patients due to risk of extrapyramidal symptoms 5

Age-Specific Considerations

  • Children are not "small adults" regarding drug safety because their growth and development affect their ability to sense and self-report drug side effects 6
  • Pharmacokinetic and pharmacodynamic parameters of drugs often differ between children and adults and must be considered before prescribing 3
  • Children at different developmental stages may have unique vulnerabilities to cardiovascular effects of medications 7

Prevention of Medication Errors

  • Parents and caregivers should receive training in proper use, storage, and administration of all drugs 3
  • Special attention should be paid to medications that can be fatal with minimal exposure, particularly in households with young children 2
  • Monitoring for adverse effects requires vigilance and education from prescribers to parents 6

Remember that medication safety in children requires consideration of age-specific risks, appropriate dosing, and careful monitoring for adverse effects. The KIDs List has been developed as a standard reference for potentially inappropriate medications in pediatric patients 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dosis Inicial de Flunarizina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Is This Medication Safe for My Child? How to Discuss Safety of Commonly Used Medications With Parents.

The journal of allergy and clinical immunology. In practice, 2022

Research

Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.